MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$26,262K
EPS
-$6.33
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
12,606
General and administrative
13,969
Operating loss
-26,575
Interest expense
207
Interest income and other income (expense), net
520
Other income (expense), net
313
Provision for income taxes
0
Net loss
-26,262
Basic EPS
-6.33
Diluted EPS
-6.33
Basic Average Shares
4,149,733
Diluted Average Shares
4,149,733
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income and otherincome (expense), net$520K Net loss-$26,262K Other income(expense), net$313K Interest expense$207K Operating loss-$26,575K General andadministrative$13,969K Research and development$12,606K

Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics, Inc. (TPST)